Oral and gut microbial profiling in periodontitis and Parkinson’s disease

References

• Stoker TB, Greenland JC. Parkinson’s Disease: Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon Publications; 2018. doi:10.15586/codonpublications.parkinsonsdisease.2018
   Google Scholar
• Sulzer D. Multiple hit hypotheses for dopamine neuron loss in Parkinson’s disease. Trends Neurosci. 2007;30(5):244–12. doi: 10.1016/j.tins.2007.03.009
   PubMed Web of Science ®Google Scholar
• DeMaagd G, Philip A. Parkinson’s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P T. 2015;40(8):504–532. doi: 10.3389/fneur.2012.00151
   PubMedGoogle Scholar
• Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912. doi: 10.1016/S0140-6736(14)61393-3
   PubMed Web of Science ®Google Scholar
• Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–1272. doi: 10.1016/S1474-4422(16)30230-7
   PubMed Web of Science ®Google Scholar
• Yang D, Zhao D, Ali Shah SZ, et al. The role of the gut microbiota in the pathogenesis of Parkinson’s disease. Front Neurol. 2019;10:1155. doi: 10.3389/fneur.2019.01155
   PubMedGoogle Scholar
• Braak H, Rüb U, Gai WP, Del Tredici K. Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna). 2003;110(5):517–536. doi: 10.1007/s00702-002-0808-2
   PubMed Web of Science ®Google Scholar
• Zhu M, Liu X, Ye Y, et al. Gut microbiota: a novel therapeutic target for Parkinson’s disease. Front Immunol. 2022;13:937555. doi: 10.3389/fimmu.2022.937555
   PubMed Web of Science ®Google Scholar
• Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. 2018;89 Suppl 1(S1):S173–S182.
   PubMedGoogle Scholar
• Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134–144. doi: 10.1111/j.1600-051x.1998.tb02419.x
   PubMed Web of Science ®Google Scholar
• Deo PN; Deshmukh R. Oral microbiome: Unveiling the fundamentals. J Oral Maxillofac Pathol. 2019;23(1):122–128. doi: 10.4103/jomfp.JOMFP_304_18
   PubMedGoogle Scholar
• Bui FQ, Almeida-da-Silva CLC, Huynh B, et al. association between periodontal pathogens and systemic disease. Biomed J. 2019,42 (1):27–35. doi: 10.1016/j.bj.2018.12.001.
   PubMed Web of Science ®Google Scholar
• Jungbauer G, Stähli A, Zhu X, et al. Periodontal microorganisms and alzheimer disease – a causative relationship? Periodontol 2000. 2022;89(1):59–82. doi: 10.1111/prd.12429.
   PubMed Web of Science ®Google Scholar
• Cicciù M, Risitano G, Lo Giudice G, Bramanti E. Periodontal health and caries prevalence evaluation in patients affected by Parkinson’s disease. Parkinsons Dis. 2012;2012:541908. doi: 10.1155/2012/541908
   PubMed Web of Science ®Google Scholar
• Lyra P, Machado V, Proença L, et al. Parkinson’s disease, periodontitis and patient-related outcomes: a cross-sectional study. Medicina (Kaunas). 2020;56(8). doi: 10.3390/medicina56080383.
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Yay E, Balci N, et al. Parkinson’s disease is positively associated with periodontal inflammation. J Periodontology. 2023;94(12):1425–1435. doi: 10.1002/JPER.23-0274
   PubMed Web of Science ®Google Scholar
• Romano S, Savva GM, Bedarf JR, et al. Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 2021;7(1):27. doi: 10.1038/s41531-021-00156-z
   PubMed Web of Science ®Google Scholar
• Yay E, Yilmaz M, Toygar H, et al. Parkinson’s disease alters the composition of subgingival microbiome. J Oral Microbiol. 2023;15(1):2250650. doi: 10.1080/20002297.2023.2250650
   PubMed Web of Science ®Google Scholar
• Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745–752. doi: 10.1136/jnnp.51.6.745
   PubMed Web of Science ®Google Scholar
• Martínez-Martín P, Gil-Nagel A, Gracia LM, et al. Unified Parkinson’s disease rating scale characteristics and structure. The cooperative multicentric group. Mov Disord. 1994;9(1):76–83. doi: 10.1002/mds.870090112
   PubMed Web of Science ®Google Scholar
• Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. 1967. Neurology. 1998;50(2):318 and 316 pages following. doi: 10.1212/wnl.50.2.318
   Web of Science ®Google Scholar
• Gürlek Ö, Gümüş P, Nile CJ, et al. Biomarkers and bacteria around implants and natural teeth in the same individuals. J Periodontol. 2017;88(8):752–761. doi: 10.1902/jop.2017.160751
   PubMed Web of Science ®Google Scholar
• Cağlayan F, Miloglu O, Altun O, et al. Oxidative stress and myeloperoxidase levels in saliva of patients with recurrent aphthous stomatitis. Oral Dis. 2008;14(8):700–704. doi: 10.1111/j.1601-0825.2008.01466.x
   PubMed Web of Science ®Google Scholar
• Armstrong MJ, Okun MS. Diagnosis and treatment of parkinson disease: a review. JAMA. 2020;323(6):548–560. doi: 10.1001/jama.2019.22360
   PubMed Web of Science ®Google Scholar
• Hill-Burns EM, Debelius JW, Morton JT, et al. Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome. Mov Disord. 2017;32(5):739–749. doi: 10.1002/mds.26942
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Liang CY, Yang LQ, et al. Association of Parkinson’s disease with microbes and microbiological therapy. Front Cell Infect Microbiol. 2021;11:619354. doi: 10.3389/fcimb.2021.619354
   PubMed Web of Science ®Google Scholar
• Liao C, Chen X, Fu Y. Salivary analysis: an emerging paradigm for non-invasive healthcare diagnosis and monitoring. Interdiscip Med. 2023;1(3). doi: 10.1002/INMD.20230009. 3
   Google Scholar
• Diao J, Yuan C, Tong P, et al. Potential roles of the free salivary microbiome dysbiosis in periodontal diseases. Front Cell Infect Microbiol. 2021;11:711282. doi: 10.3389/fcimb.2021.711282
   PubMed Web of Science ®Google Scholar
• Mihaila D, Donegan J, Barns S, et al. The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function. PLoS One. 2019;14(6):e0218252. doi: 10.1371/journal.pone.0218252
   PubMed Web of Science ®Google Scholar
• Fleury V, Zekeridou A, Lazarevic V, et al. Oral dysbiosis and inflammation in Parkinson’s disease. J Parkinsons Dis. 2021;11(2):619–631. doi: 10.3233/JPD-202459
   PubMedGoogle Scholar
• Georg LK, Brown JM. Rothia, gen. nov. An aerobic genus of the family Actinomycetaceae. IJSEM. 1967;17(1):79–88. doi: 10.1099/00207713-17-1-79
   Google Scholar
• Collins MD, Hutson RA, Falsen E, Sjöden B, Facklam RR. Description of gemella sanguinis sp. nov., isolated from human clinical specimens. J Clin Microbiol. 1998;36(10):3090–3093. doi: 10.1128/JCM.36.10.3090-3093.1998
   PubMed Web of Science ®Google Scholar
• Bor B, Bedree JK, Shi W, et al. Saccharibacteria (TM7) in the human oral microbiome. J Dent Res. 2019;98(5):500–509. doi: 10.1177/0022034519831671
   PubMed Web of Science ®Google Scholar
• Könönen E, Eerola E, Frandsen EV, et al. Phylogenetic characterization and proposal of a new pigmented species to the genus Prevotella: Prevotella pallens sp. nov. Int J Syst Bacteriol 1998;48 Pt 1(1):47–51. doi: 10.1099/00207713-48-1-47
   PubMedGoogle Scholar
• Könönen E, Fteita D, Gursoy UK, et al. Prevotella species as oral residents and infectious agents with potential impact on systemic conditions. J Oral Microbiol. 2022;14(1):2079814. doi: 10.1080/20002297.2022.2079814
   PubMed Web of Science ®Google Scholar
• Zhao T, Wei Y, Zhu Y, et al. Gut microbiota and rheumatoid arthritis: from pathogenesis to novel therapeutic opportunities. Front Immunol. 2022;13:1007165. doi: 10.3389/fimmu.2022.1007165
   PubMed Web of Science ®Google Scholar
• Meng C, Deng P, Miao R, et al. Gut microbiome and risk of ischaemic stroke: a comprehensive Mendelian randomization study. Eur J Prev Cardiol. 2023;30(7):613–620. doi: 10.1093/eurjpc/zwad052
   PubMed Web of Science ®Google Scholar
• Chen C, Liao J, Xia Y, et al. Gut microbiota regulate Alzheimer’s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut. 2022;71(11):2233–2252. doi: 10.1136/gutjnl-2021-326269
   PubMed Web of Science ®Google Scholar
• Lebouvier T, Neunlist M, Bruley des Varannes S, et al. Colonic biopsies to assess the neuropathology of Parkinson’s disease and its relationship with symptoms. PLoS One. 2010;5(9):e12728. doi: 10.1371/journal.pone.0012728
   PubMed Web of Science ®Google Scholar
• Vacca M, Celano G, Calabrese FM, et al. The controversial role of human gut lachnospiraceae. Microorganisms. 2020;8(4). doi: 10.3390/microorganisms8040573.
   PubMed Web of Science ®Google Scholar
• Tan AH, Chong CW, Lim SY, et al. Gut microbial ecosystem in parkinson disease: new clinicobiological insights from multi-omics. Ann Neurol. 2021;89(3):546–559.
   PubMed Web of Science ®Google Scholar
• Vascellari S, Palmas V, Melis M, et al. Gut microbiota and metabolome alterations associated with Parkinson’s disease. mSystems. 2020;5(5). doi: 10.1128/mSystems.00561-20
   PubMed Web of Science ®Google Scholar
• Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of Enterobacteria to the liver. PLoS One. 2015;10(7):e0134234. doi: 10.1371/journal.pone.0134234
   PubMed Web of Science ®Google Scholar
• Bao J, Li L, Zhang Y, et al. Periodontitis may induce gut microbiota dysbiosis via salivary microbiota. Int J Oral Sci. 2022;14(1):32. doi: 10.1038/s41368-022-00183-3
   PubMed Web of Science ®Google Scholar
• Morotomi M, Nagai F, Sakon H, Tanaka R. Dialister succinatiphilus sp. nov. and Barnesiella intestinihominis sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2008;58(Pt 12):2716–2720. doi: 10.1099/ijs.0.2008/000810-0.
   PubMedGoogle Scholar
• Zhang Q, Zou R, Guo M, et al. Comparison of gut microbiota between adults with autism spectrum disorder and obese adults. PeerJ. 2021;9:e10946. doi: 10.7717/peerj.10946
   PubMed Web of Science ®Google Scholar
• Shkoporov AN, Chaplin AV, Shcherbakova VA, et al. Ruthenibacterium lactatiformans gen. nov., sp. nov., an anaerobic, lactate-producing member of the family Ruminococcaceae isolated from human faeces. Int J Syst Evol Microbiol. 2016;66(8):3041–3049. doi: 10.1099/ijsem.0.001143
   PubMedGoogle Scholar
• Esmael A, Talaat M, Egila H, et al. Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings. Neurol Res. 2021;43(7):582–590. doi: 10.1080/01616412.2021.1893567
   PubMed Web of Science ®Google Scholar
• Kovtun AS, Averina OV, Angelova IY, et al. Alterations of the composition and neurometabolic profile of human gut microbiota in major depressive disorder. Biomedicines. 2022;10(9). doi: 10.3390/biomedicines10092162
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhang L, Wang X, et al. Roles of intestinal parabacteroides in human health and diseases. FEMS Microbiol Lett. 2022;369(1). doi: 10.1093/femsle/fnac072
   Web of Science ®Google Scholar
• Kverka M, Zakostelska Z, Klimesova K, et al. Oral administration of parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol. 2011;163(2):250–259. doi: 10.1111/j.1365-2249.2010.04286.x
   PubMed Web of Science ®Google Scholar